About me

Ken brings together experience in science, law, and entrepreneurship. He holds a Ph.D. in biochemistry and genetics, a law degree, and is a four-time CEO.

Ken has led the launch of several groundbreaking products. Most notably, he was the founder and strategic visionary behind AncestryDNA, which has sold over 30 million DNA tests worldwide. He also served as CEO of the company that developed a pioneering one-time gene therapy treatment and cure for adults with the bleeding disorder hemophilia B, which Pfizer now markets under the brand name Beqvez™. Throughout his career, Ken has successfully navigated numerous FDA-regulated products and diagnostics. These include the only FDA-approved saliva collection device used for detecting COVID-19, as well as a blood-based diagnostic for the early detection of liver cancer currently under FDA review. Most recently, Ken was the founder and CEO of Nectar Allergy, which reinvented allergy care through innovative science, virtual care, and an exceptional customer experience.

In addition to his entrepreneurial ventures, Ken is a professor of law and an author. As an adjunct professor, he taught patent and entrepreneurial law at the University of Utah for over a decade. He has authored more than 50 scientific, legal, and news publications, and holds 23 patents. As a patent attorney, he is a recognized expert on the patentability of genes, specializing in contract, regulatory, and privacy law. His insights have been sought by presidential committees, the National Cancer Institute, the Department of Health & Human Services, and various other federal agencies and think tanks. Ken has frequently appeared as an expert on news platforms such as PBS NewsHour and 20/20, and has given countless presentations at academic institutions and conferences. His mainstream media appearances include features on numerous television shows, including Who Do You Think You Are? and an appearance alongside Tyra Banks on America's Next Top Model.